ArticleFrontiers in pharmacology2024

Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database.

Shuang Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.